A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
Gill, Ronald G
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. [electronic resource] - Diabetes 05 2016 - 1310-6 p. digital
Publication Type: Comparative Study; Journal Article
1939-327X
10.2337/db15-0492 doi
Animals
Antibodies, Monoclonal--administration & dosage
Autoimmune Diseases--drug therapy
Biomedical Research--methods
CD3 Complex--chemistry
Diabetes Mellitus, Type 1--drug therapy
Drug Administration Schedule
Drug Therapy, Combination
Female
Immunoglobulin Fab Fragments--administration & dosage
Immunotherapy--methods
Insulin--metabolism
Insulin Secretion
Insulin-Secreting Cells--drug effects
Interleukin-1 Receptor Accessory Protein--antagonists & inhibitors
Interleukin-1beta--antagonists & inhibitors
Mice, Inbred NOD
Multicenter Studies as Topic
Pilot Projects
Receptors, Interleukin-1 Type I--antagonists & inhibitors
Recombinant Fusion Proteins--therapeutic use
Reproducibility of Results
Research Design
Specific Pathogen-Free Organisms
United States
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. [electronic resource] - Diabetes 05 2016 - 1310-6 p. digital
Publication Type: Comparative Study; Journal Article
1939-327X
10.2337/db15-0492 doi
Animals
Antibodies, Monoclonal--administration & dosage
Autoimmune Diseases--drug therapy
Biomedical Research--methods
CD3 Complex--chemistry
Diabetes Mellitus, Type 1--drug therapy
Drug Administration Schedule
Drug Therapy, Combination
Female
Immunoglobulin Fab Fragments--administration & dosage
Immunotherapy--methods
Insulin--metabolism
Insulin Secretion
Insulin-Secreting Cells--drug effects
Interleukin-1 Receptor Accessory Protein--antagonists & inhibitors
Interleukin-1beta--antagonists & inhibitors
Mice, Inbred NOD
Multicenter Studies as Topic
Pilot Projects
Receptors, Interleukin-1 Type I--antagonists & inhibitors
Recombinant Fusion Proteins--therapeutic use
Reproducibility of Results
Research Design
Specific Pathogen-Free Organisms
United States